Supramaximal Resection in Glioblastoma: Expanding Surgical Boundaries in the Era of Precision Neuro-Oncology-A Systematic Review
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Apr 2026 · 1 min read
In brief
In brief
This systematic review examines supramaximal resection (SMR) in glioblastoma—a surgical approach extending beyond traditional contrast-enhancing margins using advanced imaging and fluorescence guidance. Analysis of 37 studies suggests SMR may improve survival in selected patients, though standardization challenges limit widespread adoption.
Written by the GCMD Library team from the article.
Statements in this article
Glioblastoma remains the most aggressive and treatment-resistant primary brain tumor, with patient outcomes strongly associated with the extent of surgical resection.
Tumor recurrence is largely driven by infiltrating glioma cells that extend beyond the contrast-enhancing margin, which has traditionally served as the boundary for surgical resection.
Supramaximal resection is defined as surgical resection that extends beyond the contrast-enhancing border.
The lack of standardized definitions and methodological consistency has limited reproducibility and clinical adoption of supramaximal resection.
A total of 1045 records were identified, with 37 studies meeting inclusion criteria for this systematic review.
Supramaximal resection was frequently associated with improved progression-free and overall survival in selected patients, particularly following complete contrast-enhancing tumor resection.